OB/GYN Clinical Alert – November 1, 2002
November 1, 2002
View Issues
-
First Results from the International Breast Cancer Intervention Study (IBIS-I): A Randomized
This is the first report from a randomized, placebo-controlled trial of tamoxifen for the chemoprevention of breast cancer in women deemed to be at high risk. -
Magnesium Sulfate and PTL
In June a report emerged in the American Journal of Obstetrics and Gynecology that should get every obstetrical providers attention. -
Oral Contraceptives and Thrombosis
Øjvind Lidegaard is an obstetrician-gynecologist in Denmark who has become an epidemiologist. His case-control studies using the Denmark Registry are recognized as being as good as can be. Lidegaard and colleagues have now published 5-year case-control studies of OCs and venous thromboembolism, and cerebral thrombosis. -
Special Feature: American Women Are Not Receiving State-of-the-Art Care for Cervical Cancer
Cervical cancer is the third most common gynecologic malignancy in the United States, accounting for approximately 13,000 new cases in 2002. In this country, the major issue responsible for disparate practice patterns is one of specialty territoriality. -
Clinical Briefs in Primary Care Supplement